FAQ Library

FAQ Library published on June 7, 2016
Learn which pancreatic cancer patients should be referred to a clinical trial and which patients should not in this quick practical answer by Dr. Margaret Tempero.
FAQ Library published on May 11, 2016
Are you wondering if immune checkpoint inhibitors have a demonstrated efficacy in patients with pancreatic cancer? Dr. Philip A. Philip shares his perspective on this question.
FAQ Library published on April 13, 2016
In this FAQ, Dr. O'Reilly provides the key take away points from the genome study identifying four molecular subtypes in pancreatic cancer.
FAQ Library published on March 14, 2016
Dr. Bruera discusses the role of palliative care in patients with advanced cancer.
FAQ Library published on February 10, 2016
Dr. Margaret A. Tempero answers the question whether patients who have had surgical resection need additional treatment.
FAQ Library published on January 28, 2016
Dr. Philip A. Philip provides his perspective on combining chemotherapy and targeted therapies in patients with metastatic unresectable pancreatic cancer.
FAQ Library published on July 15, 2015 in Treatment
Dr. Koushik Das discusses the type of patients that would benefit from pancreatic cancer screening.
FAQ Library published on June 16, 2015 in Treatment
Dr. Koushik Das discusses the type of patients that would benefit from pancreatic cancer screening.
FAQ Library published on May 14, 2015 in Treatment
Dr. Koushik Das discusses screening tests and predictive biomarkers for pancreatic cancer.
FAQ Library published on March 11, 2015 in Treatment
Dr. Jill Lacy discusses radiotherapy in the treatment of pancreatic cancer, how its role is evolving in specific settings, and when and how to use radiotherapy in pancreatic cancer.
Page 2 of 5
Results 11 - 20 of 48

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2017 MediCom Worldwide, Inc. All rights reserved